XenaCare merging with Sun Packing
This article was originally published in The Tan Sheet
Delray Beach, Fla.-based nutritional product firm XenaCare Holdings, which is launching the SunPill supplement designed to help protect skin, announced Aug. 22 it filed with the Securities and Exchange Commission to merge with Houston -based Sun Packing. Through the deal expected to close by October, XenaCare says it will put Sun Packing in charge of 50.1 percent of shares in the merged company. The merger "will reflect a combined business entity with expected first year sales in excess of $15 million and the capability" to apply for NASDAQ or American Stock Exchange Listing, says XenaCare President Frank Rizzo. XenaCare says a new name reflecting both businesses may be developed
You may also be interested in...
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
Tests used to detect cytomegalovirus in organ transplant patients may face an easier path to market under a proposed rule that the US Food and Drug Administration released on 18 September. See what the regulatory agency said about it here.
While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.